Posaconazole Tablet, Delayed Release
Product Images NDC 71335-2665

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 71335-2665). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352665)

This text appears to be a description of a pharmaceutical product. It mentions a tablet containing 100 mg of Posaconazole, advising storage between 20°C to 25°C with excursions permitted between 15°C to 30°C. The text also cautions that the oral suspension and delayed-release tablets of Noxafil are not interchangeable due to differences in dosing. The product is repackaged by Bryant Ranch Prepack, Inc. and made by i3 Pharmaceuticals, LLC. The usual dosage information is provided. It emphasizes keeping the medication out of reach of children.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.